Lazard Asset Management
PAHC icon

Lazard Asset Management’s Phibro Animal Health PAHC Stock Holding History

Lazard Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.06M Buy
145,811
+14,944
+11% +$711K 0.01% 458
2025
Q4 		$4.89M Buy
130,867
+30,498
+30% +$1.24M 0.01% 557
2025
Q3 		$4.06M Buy
100,369
+7,928
+9% +$262K 0.01% 639
2025
Q2 		$2.36M Buy
92,441
+89,794
+3,392% +$1.96M ﹤0.01% 961
2025
Q1 		$56K Buy
2,647
+1,000
+61% +$22.4K ﹤0.01% 1969
2024
Q4 		$34K Buy
1,647
+1,589
+2,740% +$36.8K ﹤0.01% 2036
2024
Q3 		$1K Sell
58
-2,065
-97% -$39.9K ﹤0.01% 2188
2024
Q2 		$35K Buy
+2,123
New +$34.1K ﹤0.01% 1977
2022
Q4 		– Sell
-6,424
Closed -$85K – 2518
2022
Q3 		$85K Hold
6,424
– – ﹤0.01% 1545
2022
Q2 		$122K Buy
+6,424
New +$122K ﹤0.01% 1444
2022
Q1 		– Sell
-2,630
Closed -$53K – 2474
2021
Q4 		$53K Buy
2,630
+369
+16% +$7.88K ﹤0.01% 1714
2021
Q3 		$48K Buy
+2,261
New +$54.4K ﹤0.01% 1702
2021
Q1 		– Sell
-1,721
Closed -$33K – 1970
2020
Q4 		$33K Buy
+1,721
New +$31.7K ﹤0.01% 1534
2016
Q2 		– Sell
-730,756
Closed -$19.8M – 1091
2016
Q1 		$19.8M Sell
730,756
-42,224
-5% -$1.21M 0.04% 249
2015
Q4 		$23.3M Buy
772,980
+239,590
+45% +$7.69M 0.05% 231
2015
Q3 		$16.9M Buy
533,390
+24,000
+5% +$876K 0.04% 257
2015
Q2 		$19.8M Sell
509,390
-65,129
-11% -$2.25M 0.04% 258
2015
Q1 		$20.3M Sell
574,519
-297,604
-34% -$9.58M 0.04% 246
2014
Q4 		$27.5M Sell
872,123
-165,996
-16% -$4.59M 0.06% 216
2014
Q3 		$23.3M Buy
1,038,119
+61,614
+6% +$1.23M 0.05% 235
2014
Q2 		$21.4M Buy
+976,505
New +$18.6M 0.04% 253

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lazard Asset Management's PAHC Position: Q1 2026 in Review

Lazard Asset Management increased its Phibro Animal Health (PAHC) stake by 11% in Q1 2026, buying an estimated $711K and bringing the position to 145,811 shares worth $8.06M. The position accounts for 0.01% of the portfolio, ranked #458.

Lazard Asset Management first reported a position in PAHC in Q2 2014 and has held it in 21 quarters since. The position peaked at $27.5M in Q4 2014. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Lazard Asset Management held 145,811 shares of Phibro Animal Health worth $8.06M as of Q1 2026.
  • Lazard Asset Management bought 14,944 Phibro Animal Health shares in Q1 2026, an estimated $711K.
  • Phibro Animal Health made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #458 holding.
  • Lazard Asset Management first reported a position in Phibro Animal Health in Q2 2014 and has held it in 21 quarters since.
  • Lazard Asset Management's Phibro Animal Health position peaked at $27.5M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.